Date:26/10/2004 URL: http://www.thehindubusinessline.com/2004/10/26/stories/2004102601980202.htm

Back Glenmark net doubles

Our Bureau

MUMBAI: Glenmark Pharmaceuticals Ltd has clocked a 101.11 per cent growth in net profit, at Rs 28.94 crore, for the second quarter ended September 30, 2004.

The company has registered a 51.7 per cent growth in revenue, clocking Rs 160.25 crore in the same period.

Glenmark has promoted four new products during the last quarter including Mignar (Miglitol), Carboflot (Carbonyl Iron), L-Cetridoc (Levocetrizine) and Mucaryl AX, a company communiqué said.

The company has also filed 50 additional registrations in several of its export markets and commenced the export of 40 additional products for which registrations were granted in the quarter, it added.